No Data
Oramed Pharmaceuticals (ORMP): Shareholder Letter Spurs Bullish Trend
After releasing a letter to shareholders, Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) shares has seen a significant increase on the US stock charts. As of the latest current-market check, ORMP stock price increased 18.82% to $2.66. Program For Stock Repurchases And Strategic Update Nadav Kidron, the CEO of Oramed Pharmaceuticals (ORMP), sent a detailed letter to ...
Oramed Pharmaceuticals Shares Are Trading Higher After the Company Announced a $20 Million Buyback Program and Finalized Its Joint Venture With Hefei Tianhui Biotech.
Oramed Pharmaceuticals Shares Are Trading Higher After the Company Announced a $20 Million Buyback Program and Finalized Its Joint Venture With Hefei Tianhui Biotech.
Express News | Oramed Pharmaceuticals: Htit Committing $70 Mln in Cash, Co Investing $25 Mln in Cash & Stock in Jv
Express News | Oramed Pharmaceuticals Inc: Jv With Chinese Partner, Htit
Express News | Oramed Pharmaceuticals - Authorized Common Stock Repurchase Plan Allowing for Buy-Back of up to $20 Mln in Maximum Value of Its Common Stock
Express News | Oramed Pharmaceuticals Inc. Announces the Buy-Back of Its Common Stock